Literature DB >> 25799451

An 8-Year Follow-up on the Effect of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease.

Yu Jin Jung1, Han-Joon Kim2, Beom S Jeon2, Hyeyoung Park2, Woong-Woo Lee2, Sun Ha Paek3.   

Abstract

IMPORTANCE: Pain is a common and distressing feature in Parkinson disease (PD). The major indication of subthalamic nucleus deep brain stimulation (STN DBS) is motor complications in advanced PD; however, pain reduction after STN DBS has been noted.
OBJECTIVE: To evaluate the long-term effect of STN DBS on pain in PD. DESIGN, SETTING, AND PARTICIPANTS: Twenty-four patients who underwent STN DBS at the Movement Disorder Center at Seoul National University Hospital from June 1, 2005, through March 31, 2006, were studied. The assessments of pain were performed preoperatively and 8 years after surgery. Because 13 of the total 24 patients had additional 2-year postoperative data, the serial change between the preoperative and the 2- and 8-year follow-ups after surgery was also evaluated. MAIN OUTCOMES AND MEASURES: Motor symptoms were assessed using the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr staging scale. The severity of pain was scored according to an ordinal scale ranging from 0 (absent) to 10 (maximal pain) in 7 parts of the body (head, neck, trunk, and the upper and lower extremities on each side of the body). For each body part, the quality of pain was grouped into 1 of 4 categories: dystonic, musculoskeletal, radiculoneuritic, and central.
RESULTS: Sixteen of the 24 patients (67%) experienced pain at baseline when not taking medication (off-state). All off-state pain at baseline improved or disappeared at 8 years after surgery. The number of body parts with pain was 21 at baseline and decreased to 11 at 8 years after the surgery. The mean (SD) and median scores of the off-state pain were 6.2 (2.5) and 7.0 at baseline and improved to 3.5 (2.2) and 2.5 at 8 years after the surgery, respectively. However, new pain developed in 18 of 24 patients (75%) during the 8-year follow-up period. The number of body parts with newly developed pain was 47, and the mean (SD) and median scores for new pain were 4.4 (3.0) and 3.0, respectively. The types of new pain at 8 years were musculoskeletal in 11 patients, central in 4 patients, radiculoneuritic in 3 patients, and dystonic in 1 patient. CONCLUSIONS AND RELEVANCE: Pain associated with PD is improved by STN DBS, and the beneficial effect persists after a long-term follow-up of 8 years. In addition, new pain, especially the musculoskeletal type, developed in most patients, becoming a long-term distressing problem.

Entities:  

Mesh:

Year:  2015        PMID: 25799451     DOI: 10.1001/jamaneurol.2015.8

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  21 in total

1.  The prevalence of chronic low back pain and lumbar deformities in patients with Parkinson's disease: implications on spinal surgery.

Authors:  Imke Galazky; Christina Caspari; Hans-Jochen Heinze; Joerg Franke
Journal:  Eur Spine J       Date:  2018-09-08       Impact factor: 3.134

Review 2.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

3.  Functional MRI Signature of Chronic Pain Relief From Deep Brain Stimulation in Parkinson Disease Patients.

Authors:  Marisa DiMarzio; Tanweer Rashid; Ileana Hancu; Eric Fiveland; Julia Prusik; Michael Gillogly; Radhika Madhavan; Suresh Joel; Jennifer Durphy; Eric Molho; Era Hanspal; Damian Shin; Julie G Pilitsis
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

4.  Evaluation of preoperative efficacy of levodopa in subthalamic deep brain stimulation.

Authors:  Wen Liu; Xiumin Zhang; Pan Nie; Lidao Chen; Kai Fu; Jibo Zhang; Jincao Chen; Jie Zhang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 5.  Pain in Parkinson's disease and the role of the subthalamic nucleus.

Authors:  Abteen Mostofi; Francesca Morgante; Mark J Edwards; Peter Brown; Erlick A C Pereira
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

Review 6.  Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek
Journal:  J Mov Disord       Date:  2015-05-31

Review 7.  Update on Deep Brain Stimulation for Dyskinesia and Dystonia: A Literature Review.

Authors:  Hiroki Toda; Hidemoto Saiki; Namiko Nishida; Koichi Iwasaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-06       Impact factor: 1.742

8.  A Meta-Analysis of the Effect of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson's Disease-Related Pain.

Authors:  Yu Diao; Yutong Bai; Tianqi Hu; Zixiao Yin; Huangguang Liu; Fangang Meng; Anchao Yang; Jianguo Zhang
Journal:  Front Hum Neurosci       Date:  2021-07-01       Impact factor: 3.169

Review 9.  The Current Status of Deep Brain Stimulation for the Treatment of Parkinson Disease in the Republic of Korea.

Authors:  Jung-Il Lee
Journal:  J Mov Disord       Date:  2015-09-10

Review 10.  Pain management in patients with Parkinson's disease: challenges and solutions.

Authors:  Orjan Skogar; Johan Lokk
Journal:  J Multidiscip Healthc       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.